Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience
Gianfranco Lauletta, Sabino Russi, Fabio Pavone, et al.
Arthritis Research & Therapy (2017) Vol. 19, Iss. 1
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Marc G. Ghany, Timothy R. Morgan
Hepatology (2019) Vol. 71, Iss. 2, pp. 686-721
Open Access | Times Cited: 861
Cryoglobulinaemia
Dario Roccatello, David Saadoun, Manuel Ramos‐Casals, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 173
Extrahepatic Manifestations of Chronic HCV Infection
P. Cacoub, David Saadoun
New England Journal of Medicine (2021) Vol. 384, Iss. 11, pp. 1038-1052
Closed Access | Times Cited: 134
EASL position paper on clinical follow-up after HCV cure
Thomas Reiberger, Sabela Lens, Giuseppe Cabibbo, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 326-344
Closed Access | Times Cited: 24
KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

Kidney International Supplements (2018) Vol. 8, Iss. 3, pp. 91-165
Open Access | Times Cited: 151
Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis
P. Cacoub, A.C. Desbois, Cloé Comarmond, et al.
Gut (2018) Vol. 67, Iss. 11, pp. 2025-2034
Open Access | Times Cited: 126
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy
Cesare Mazzaro, Luca Quartuccio, Luigi Elio Adinolfi, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2249-2249
Open Access | Times Cited: 78
Extrahepatic cancers and chronic HCV infection
Stanislas Pol, Anaïs Vallet‐Pichard, Olivier Hermine
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 5, pp. 283-290
Closed Access | Times Cited: 83
KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
Michel Jadoul, Ahmed A. Awan, Marina Berenguer, et al.
Kidney International (2022) Vol. 102, Iss. 6, pp. S129-S205
Open Access | Times Cited: 33
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis
Franco Dammacco, Gianfranco Lauletta, Sabino Russi, et al.
Clinical and Experimental Medicine (2018) Vol. 19, Iss. 1, pp. 1-21
Closed Access | Times Cited: 51
The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements
Franco Dammacco, Gianfranco Lauletta, Angelo Vacca
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 2, pp. 255-272
Open Access | Times Cited: 21
A prospective study of direct‐acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort
Loreta A. Kondili, Monica Monti, Maria Giovanna Quaranta, et al.
Hepatology (2021) Vol. 76, Iss. 1, pp. 220-232
Open Access | Times Cited: 26
Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
Iman Ibrahim Salama, Hala M. Raslan, Ghada A. Abdel-Latif, et al.
World Journal of Hepatology (2022) Vol. 14, Iss. 6, pp. 1053-1073
Open Access | Times Cited: 18
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals
Antonio Tonutti, Davide Polverini, Stella De Nicola, et al.
Expert Review of Anti-infective Therapy (2025), pp. 1-12
Closed Access
Hepatitis C associated mixed cryoglobulinemia glomerulonephritis in the setting of undetectable viral load: successful treatment with hydroxychloroquine and review of the literature
Faris Shweikeh, Yaritza Torres, Khalid M. Khan, et al.
Immunologic Research (2025) Vol. 73, Iss. 1
Closed Access
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis
Laura Gragnani, Guia Cerretelli, Serena Lorini, et al.
Alimentary Pharmacology & Therapeutics (2018) Vol. 48, Iss. 4, pp. 440-450
Open Access | Times Cited: 31
The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia
Ahmed El‐Shamy, Andrea D. Branch, Thomas D. Schiano, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 28
Direct‐acting antiviral agents for hepatitis C virus‐mixed cryoglobulinaemia: dissociated virological and haematological responses
Gabriele Pozzato, Cesare Mazzaro, Marina Artemova, et al.
British Journal of Haematology (2020) Vol. 191, Iss. 5, pp. 775-783
Open Access | Times Cited: 26
Liver Disease–Associated Glomerulopathies
Swetha Rani Kanduri, Yonatan Peleg, Shikha Wadhwani
Advances in Kidney Disease and Health (2024) Vol. 31, Iss. 2, pp. 147-156
Closed Access | Times Cited: 3
Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy
Cesare Mazzaro, Luigino Dal Maso, Endri Mauro, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 8, pp. 102589-102589
Open Access | Times Cited: 23
Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational study
Gianfranco Lauletta, Sebastiano Cicco, F Dammacco
Minerva Medica (2024) Vol. 115, Iss. 3
Closed Access | Times Cited: 2
Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience
M Gambacorti Passerini, Monica Schiavini, C. Magni, et al.
European Journal of Gastroenterology & Hepatology (2018) Vol. 30, Iss. 10, pp. 1208-1215
Closed Access | Times Cited: 19
Cryoglobulinemic vasculitis and glomerulonephritis
Yi‐pu Chen, Hong Cheng, Hongliang Rui, et al.
Chinese Medical Journal (2019) Vol. 132, Iss. 14, pp. 1723-1732
Open Access | Times Cited: 18
Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life
Laura Gragnani, Serena Lorini, Silvia Marri, et al.
Autoimmunity Reviews (2021) Vol. 21, Iss. 1, pp. 102923-102923
Closed Access | Times Cited: 16
Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review
Bogdan Obrișcă, Roxana Jurubiță, Bogdan Sorohan, et al.
Clinical Rheumatology (2019) Vol. 38, Iss. 12, pp. 3677-3687
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top